1. Limited CD4+ T-cell renewal in early HIV-1 infection: effect of highly active antiretroviral therapy.
- Author
-
Fleury S, de Boer RJ, Rizzardi GP, Wolthers KC, Otto SA, Welbon CC, Graziosi C, Knabenhans C, Soudeyns H, Bart PA, Gallant S, Corpataux JM, Gillet M, Meylan P, Schnyder P, Meuwly JY, Spreen W, Glauser MP, Miedema F, and Pantaleo G
- Subjects
- Adult, Aged, CD4-CD8 Ratio, CD8-Positive T-Lymphocytes immunology, Carbamates, Cell Division, Drug Therapy, Combination, Female, Furans, Humans, Ki-67 Antigen metabolism, Lymph Nodes metabolism, Male, Middle Aged, Anti-HIV Agents therapeutic use, CD4-Positive T-Lymphocytes immunology, Dideoxynucleosides therapeutic use, HIV Infections drug therapy, HIV Infections immunology, HIV Protease Inhibitors therapeutic use, Reverse Transcriptase Inhibitors therapeutic use, Sulfonamides therapeutic use
- Abstract
We show that the fraction of proliferating CD4+ lymphocytes is similar in HIV-infected subjects in the early stage of disease and in HIV-negative subjects, whereas the fraction of proliferating CD8+ lymphocytes is increased 6.8-fold in HIV-infected subjects. After initiation of antiviral therapy, there is a late increase in proliferating CD4+ T cells associated with the restoration of CD4+ T-cell counts. These results provide strong support for the idea of limited CD4+ T-cell renewal in the early stage of HIV infection and indicate that after effective suppression of virus replication, the mechanisms of CD4+ T-cell production are still functional in early HIV infection.
- Published
- 1998
- Full Text
- View/download PDF